{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:30:01Z","timestamp":1740547801823,"version":"3.38.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2010,9,9]],"date-time":"2010-09-09T00:00:00Z","timestamp":1283990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s00292-010-1335-9","type":"journal-article","created":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T22:41:28Z","timestamp":1283899288000},"page":"268-273","source":"Crossref","is-referenced-by-count":5,"title":["Mikrosatelliteninstabilit\u00e4t","Microsatellite instability"],"prefix":"10.1007","volume":"31","author":[{"given":"W.","family":"Dietmaier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,9]]},"reference":[{"key":"1335_CR1","doi-asserted-by":"crossref","unstructured":"Andre T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer, N Engl J Med 350:2343\u20132351","DOI":"10.1056\/NEJMoa032709"},{"key":"1335_CR2","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","volume":"27","author":"Andre","year":"2009","unstructured":"Andre T, Boni C, Navarro M et al (2009) Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109\u20133116","journal-title":"J Clin Oncol"},{"key":"1335_CR3","first-page":"5248","volume":"58","author":"Boland","year":"1998","unstructured":"Boland CR, Thibodeau SN, Hamilton SR et al (1998) A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248\u20135257","journal-title":"Cancer Res"},{"key":"1335_CR4","first-page":"4749","volume":"57","author":"Dietmaier","year":"1997","unstructured":"Dietmaier W, Wallinger S, Bocker T et al (1997) Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 57:4749\u20134756","journal-title":"Cancer Res"},{"key":"1335_CR5","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/ijc.21620","volume":"118","author":"Dietmaier","year":"2006","unstructured":"Dietmaier W, Bettstetter M, Wild PJ et al (2006) Nuclear Maspin expression is associated with response to adjuvant 5-fluorouracil based chemotherapy in patients with stage III colon cancer. Int J Cancer 118:2247\u20132254","journal-title":"Int J Cancer"},{"key":"1335_CR6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1200\/JCO.2005.01.086","volume":"23","author":"Popat","year":"2005","unstructured":"Popat S, Hubner R, Houlston RS (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23:609\u2013618","journal-title":"J Clin Oncol"},{"key":"1335_CR7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1200\/JCO.2009.23.3452","volume":"28","author":"Roth","year":"2010","unstructured":"Roth AD, Tejpar S, Delorenzi M et al (2010) Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60\u201300 trial. J Clin Oncol 28:466\u2013474","journal-title":"J Clin Oncol"},{"key":"1335_CR8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/gut.2007.135004","volume":"57","author":"Walther","year":"2008","unstructured":"Walther A, Houlston R, Tomlinson I (2008) Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 57:941\u2013950","journal-title":"Gut"},{"key":"1335_CR9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/CCO.0b013e32832c94bd","volume":"21","author":"Sinicrope","year":"2009","unstructured":"Sinicrope FA, Sargent DJ (2009) Clinical implications of microsatellite instability in sporadic colon cancers. Curr Opin Oncol 21:369\u2013373","journal-title":"Curr Opin Oncol"},{"key":"1335_CR10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0026-895X(25)13467-6","volume":"28","author":"Fram","year":"1985","unstructured":"Fram RJ, Cusick PS, Wilson JM et al (1985) Mismatch repair of cis-diamminedichloroplatinum(II)-induced DNA damage. Mol Pharmacol 28:51\u201355","journal-title":"Mol Pharmacol"},{"key":"1335_CR11","first-page":"5193","volume":"61","author":"Meyers","year":"2001","unstructured":"Meyers M, Wagner MW, Hwang HS et al (2001) Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses. Cancer Res 61:5193\u20135201","journal-title":"Cancer Res"},{"key":"1335_CR12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0016-5085(99)70558-5","volume":"117","author":"Carethers","year":"1999","unstructured":"Carethers JM, Chauhan DP, Fink D et al (1999) Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology 117:123\u2013131","journal-title":"Gastroenterology"},{"key":"1335_CR13","doi-asserted-by":"crossref","unstructured":"Hewish M, Lord CJ, Martin SA et al (o J) Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nat Rev Clin Oncol 7:197\u2013208","DOI":"10.1038\/nrclinonc.2010.18"},{"key":"1335_CR14","doi-asserted-by":"crossref","unstructured":"Tajima A, Hess MT, Cabrera BL et al (2004) The mismatch repair complex hMutS alpha recognizes 5-fluorouracil-modified DNA: implications for chemosensitivity and resistance. Gastroenterology. 127:1678\u20131684","DOI":"10.1053\/j.gastro.2004.10.001"},{"key":"1335_CR15","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(00)02261-3","volume":"355","author":"Elsaleh","year":"2000","unstructured":"Elsaleh H, Joseph D, Grieu F et al (2000) Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 355:1745\u20131750","journal-title":"Lancet"},{"key":"1335_CR16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1056\/NEJMoa022289","volume":"349","author":"Ribic","year":"2003","unstructured":"Ribic CM, Sargent DJ, Moore MJ et al (2003) Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349:247\u2013257","journal-title":"N Engl J Med"},{"key":"1335_CR17","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.ejca.2009.04.018","volume":"45","author":"Des","year":"2009","unstructured":"Des Guetz G, Schischmanoff O, Nicolas P et al (2009) Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis. Eur J Cancer 45:1890\u20131896","journal-title":"Eur J Cancer"},{"key":"1335_CR18","first-page":"5738","volume":"63","author":"Fallik","year":"2003","unstructured":"Fallik D, Borrini F, Boige V et al (2003) Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer. Cancer Res 63:5738\u20135744","journal-title":"Cancer Res"},{"key":"1335_CR19","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1200\/JCO.2008.18.2071","volume":"27","author":"Bertagnolli","year":"2009","unstructured":"Bertagnolli MM, Niedzwiecki D, Compton CC et al (2009) Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and leukemia group b protocol 89803. J Clin Oncol 27:1814\u20131821","journal-title":"J Clin Oncol"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-010-1335-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-010-1335-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-010-1335-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T16:47:12Z","timestamp":1740502032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-010-1335-9"}},"subtitle":["Ein neuer pr\u00e4diktiver Marker (?)","A new predictive marker (?)"],"short-title":[],"issued":{"date-parts":[[2010,9,9]]},"references-count":19,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["1335"],"URL":"https:\/\/doi.org\/10.1007\/s00292-010-1335-9","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"type":"print","value":"0172-8113"},{"type":"electronic","value":"1432-1963"}],"subject":[],"published":{"date-parts":[[2010,9,9]]}}}